Karyopharm Therapeutics Inc (KPTI)

[surf1944]

8:32AM Karyopharm Therapeutics receives Award of grant from National Multiple Sclerosis Society to further develop selective inhibitors of nuclear export compounds (KPTI) 22.73 : Co announces that it has been awarded a grant from the National Multiple Sclerosis Society through its affiliate, Fast Forward, to support research on the potential of SINE compounds in inflammatory models of disease, including MS. Finding ways to restore and protect the damaged nervous system is a key priority of the National MS Society's No Opportunity Wasted research campaign to ultimately eradicate MS. No further details were provided at this time.